Spect provides a portable retinal camera and a telemedicine platform that enables healthcare providers to conduct diabetic retinopathy screenings and other retinal exams in under three minutes, using existing medical staff. This solution addresses the critical shortage of eye specialists and the low rates of annual eye exams among diabetic patients, facilitating early detection of preventable vision loss.
Funding
$5.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
XVFounders
Product
Problem
A shortage of eye specialists and low rates of annual eye exams, particularly among diabetic patients, hinder the early detection of preventable vision loss. Traditional retinal exams often require referrals to specialists, creating barriers to access and delaying diagnosis.
Solution
Spect provides a vertically integrated platform for retinal exams, enabling healthcare providers to conduct diabetic retinopathy screenings and other retinal assessments in under three minutes using existing medical staff. The platform includes a portable retinal camera that is easy to use and seamlessly integrates into clinical workflows, allowing exams to be performed in the clinic or at the patient's home. Images captured by the camera are uploaded to a telemedicine platform and graded by board-certified ophthalmologists, with diagnostic reports returned within 24 hours. The platform facilitates early detection of eye diseases, including diabetic retinopathy and macular degeneration, and ensures high gradability of images.
Target Audience
The primary customers are accountable care organizations, community health centers, payors, health systems, independent physician associations, primary care providers, street medicine programs, at-home care providers, senior care facilities, employer-based health programs, endocrinology practices, direct primary care providers, and Indian Health services.
Features
- Portable retinal camera designed for ease of use and integration into existing clinical workflows
- Retinal exams can be completed in under 3 minutes
- Human-in-the-loop assisted telemedicine platform ensures quick dilated exams and gradability above 95%
- Diagnostic reports are generated by board-certified ophthalmologists and returned within 24 hours
- The platform screens for diabetic retinopathy, stages of dry macular degeneration, and end-stage wet macular degeneration
- FDA Class 2 Exempt
- SOC 2 Type 1 Certification
- HIPAA Compliance
- EMR + EHR Integration